分枝杆菌病的个性化医疗方法。
Personalized medicine approach in mycobacterial disease.
作者信息
Mirsaeidi Mehdi
机构信息
Division of Pulmonary and Critical Care, University of Illinois at Chicago, Chicago, IL, USA.
出版信息
Int J Mycobacteriol. 2012 Jun;1(2):59-64. doi: 10.1016/j.ijmyco.2012.03.001.
Abstract
Mycobacterial diseases are a group of illnesses that cause a considerable number of deaths throughout the world, regardless of years of public health control efforts. Personalized medicine is a new but rapidly advancing field of healthcare. Personalized medicine in the field of mycobacteriology may be applied in the different levels of management such as prevention, diagnosis, treatment and prognosis. A genetic predisposition and a protein dysfunction study are recommended to tailor an individual approach in mycobacterial diseases.
摘要
分枝杆菌病是一类在全球导致大量死亡的疾病，尽管进行了多年的公共卫生防控努力。个性化医疗是一个新兴但发展迅速的医疗保健领域。分枝杆菌学领域的个性化医疗可应用于预防、诊断、治疗和预后等不同管理层面。建议开展遗传易感性和蛋白质功能障碍研究，以便为分枝杆菌病制定个体化治疗方案。
相似文献
1
Personalized medicine approach in mycobacterial disease.
Int J Mycobacteriol. 2012 Jun;1(2):59-64. doi: 10.1016/j.ijmyco.2012.03.001.
2
[Biologics and mycobacterial diseases].
Kekkaku. 2013 Mar;88(3):337-53.
3
[Development of antituberculous drugs: current status and future prospects].
Kekkaku. 2006 Dec;81(12):753-74.
4
Hospital costs in the US for pulmonary mycobacterial diseases.
Int J Mycobacteriol. 2015 Sep;4(3):217-221. doi: 10.1016/j.ijmyco.2015.05.003.
5
[Recent progress in mycobacteriology].
Kekkaku. 2007 Oct;82(10):783-99.
6
Abdominal nontuberculous mycobacterial infection in a university hospital in Taiwan from 1997 to 2003.
J Formos Med Assoc. 2006 May;105(5):370-6. doi: 10.1016/S0929-6646(09)60132-7.
7
Epidemiology and clinical characteristic of mycobacterial infections in human immunodeficiency virus-infected patients in Siriraj Hospital.
J Med Assoc Thai. 2015 Mar;98(3):238-44.
8
9
Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study.
Am J Respir Crit Care Med. 1999 Jan;159(1):94-9. doi: 10.1164/ajrccm.159.1.9803048.
10
A Global Survey of Mycobacterial Diversity in Soil.
Appl Environ Microbiol. 2019 Aug 14;85(17). doi: 10.1128/AEM.01180-19. Print 2019 Sep 1.
引用本文的文献
1
Exome Sequencing Identifies a Novel Mutation in Recessive Atypical Combined Immunodeficiency.
Front Immunol. 2017 Nov 27;8:1624. doi: 10.3389/fimmu.2017.01624. eCollection 2017.
2
Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects.
Biomed Res Int. 2015;2015:523697. doi: 10.1155/2015/523697. Epub 2015 Jun 16.
3
Highlight on advances in nontuberculous mycobacterial disease in North America.
Biomed Res Int. 2014;2014:919474. doi: 10.1155/2014/919474. Epub 2014 Sep 11.
4
Management of nontuberculous mycobacterial infection in the elderly.
Eur J Intern Med. 2014 Apr;25(4):356-63. doi: 10.1016/j.ejim.2014.03.008. Epub 2014 Mar 29.
本文引用的文献
1
An update of preimplantation genetic diagnosis in gene diseases, chromosomal translocation, and aneuploidy screening.
Clin Exp Reprod Med. 2011 Sep;38(3):126-34. doi: 10.5653/cerm.2011.38.3.126. Epub 2011 Sep 30.
2
Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.
Am J Respir Crit Care Med. 2012 Apr 15;185(8):881-6. doi: 10.1164/rccm.201111-2016OC. Epub 2012 Feb 3.
3
A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians.
BMC Med Genet. 2012 Jan 13;13:5. doi: 10.1186/1471-2350-13-5.
4
CCL2−2518 (A/G) polymorphisms and tuberculosis susceptibility: a meta-analysis.
Int J Tuberc Lung Dis. 2012 Feb;16(2):150-6. doi: 10.5588/ijtld.11.0205.
5
Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
Tissue Antigens. 2012 Feb;79(2):90-6. doi: 10.1111/j.1399-0039.2011.01812.x. Epub 2011 Nov 30.
6
Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA).
J Genet Couns. 2012 Apr;21(2):345-52. doi: 10.1007/s10897-011-9405-6. Epub 2011 Sep 7.
7
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Pathol Biol (Paris). 2012 Oct;60(5):324-30. doi: 10.1016/j.patbio.2011.07.001.
8
Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts.
Br Med Bull. 2010;96:45-59. doi: 10.1093/bmb/ldq035. Epub 2010 Oct 25.
9
Association of genetic polymorphisms in the IL12-IFNG pathway with susceptibility to and prognosis of pulmonary tuberculosis in a Chinese population.
Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1291-5. doi: 10.1007/s10096-010-0985-0. Epub 2010 Jun 11.
10
Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease.
Am J Respir Crit Care Med. 2010 Oct 1;182(7):977-82. doi: 10.1164/rccm.201003-0503OC. Epub 2010 May 27.
Zotero 插件